Screener
Dianthus Therapeutics DNTH Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Dianthus Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Dianthus Therapeutics’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001690585-26-000022
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 1,119,911 | 409,438 |
| Long-term investments | 113,868 | 110,135 |
| Property and equipment, net | 274 | 296 |
| Right-of-use operating lease assets | 1,293 | 1,337 |
| Other assets and restricted cash | 11,538 | 9,716 |
| Total assets | $1,246,884 | $530,922 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dianthus Therapeutics's operating lease ROU assets?
- Dianthus Therapeutics (DNTH) reported operating lease ROU assets of $1.29M in Q1 2026.
- How has Dianthus Therapeutics's operating lease ROU assets changed year-over-year?
- Dianthus Therapeutics's operating lease ROU assets decreased by 10.6% year-over-year, from $1.45M to $1.29M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Dianthus Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude